Home › Graves Disease › Missouri › Kansas City
Graves Disease clinical trials in Kansas City, MO
3 studies for Graves Disease are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
- Site-004, Kansas City
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
RecruitingPhase 3
- Truman Medical Center, Kansas City
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1004, Kansas City
Graves Disease trials in other cities
- Miami, FL7 studies
- Dallas, TX7 studies
- Houston, TX6 studies
- San Antonio, TX5 studies
- Memphis, TN3 studies
- Akron, OH3 studies
- Doral, FL3 studies
- McKinney, TX3 studies
- Hialeah, FL3 studies
- Tucson, AZ3 studies
- El Paso, TX3 studies
- Havelock, NC3 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.